USPTO serial 79365170
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bradley M. Stohry
Bradley M. Stohry Reichel Stohry Dean LLP6151 Central AveIndianapolis, IN 46220United States| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business management, advice and assistance; business administration; human resources management and employment recruitment services; creating and developing training plans and career development; administering of professional competency testing; testing to determine professional competency; information, advisory and consultancy services in relation to all of the aforementioned services | ACTIVE | — |
| 041 | Training and education services, namely conferences, exhibitions and seminars in the field of quality evaluation, checking, auditing and assurance services in the field of clinical research and clinical trial site competency, practices and processes to determine conformity with certification standards; training and education services, namely conferences, exhibitions and seminars in the field of professional competency; training and education services, namely conferences, exhibitions and seminars in the field of clinical research competency; training and education services, namely conferences, exhibitions and seminars in the field of employee competency; training and education services, namely, conferences, exhibitions and seminars in the field of employer competency; training and education services, namely conferences, exhibitions and seminars in the field of business competency; organization competency training and education services, namely conferences, exhibitions and seminars in the field of quality evaluation, checking, auditing and assurance services in the field of clinical research and clinical trial site competency, practices and processes; training and education services, namely conferences, exhibitions and seminars in the field of workforce quality; training and education services, namely conferences, exhibitions and seminars in the field of conducting, management and operation of clinical research and clinical trials; organisation of events, conferences, exhibitions and seminars in the field of quality evaluation, checking, auditing and assurance services in the field of clinical research and clinical trial site competency, practices and processes to determine conformity with certification standards for educational or training purposes; educational examination services, namely, educational testing and conducting of examinations; providing recognition and incentives by the way of certificates and awards to demonstrate excellence in the field of clinical research and clinical trial site competency; information, advisory and consultancy services in relation all of the aforementioned services | ACTIVE | — |
| 042 | Evaluating organizations to determine whether the organizations conform to an established accreditation standard; Testing, analysis and evaluation of service providers to determine conformity with established accreditation standards; testing, analysis and evaluation of clinical research and clinical research sites to determine conformity with established accreditation standards; testing services for the certification of quality or standards namely, quality evaluation, checking, auditing and assurance in the field of clinical research and clinical research site competency, practices and processes; providing quality assurance services in the field of clinical research and clinical trial site competency, practices and processes to determine conformity with certification standards; quality assurance consultancy; clinical research services in the field of quality evaluation, checking, auditing and assurance services in the field of clinical research and clinical trial site competency, practices and processes to determine conformity with certification standards; clinical trials, namely the evaluation, checking, auditing and assurance of clinical research sites and clinical trial sites to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; certification services in relation to professional competency, namely the evaluation, checking, auditing and assurance of clinical research sites and clinical trial sites to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; certification services in relation to employee competency, namely the evaluation, checking, auditing and assurance of others to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; certification services in relation to employer competency, namely the evaluation, checking, auditing and assurance of others to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; certification services in relation to business competency, namely the evaluation, checking, auditing and assurance of clinical research sites and clinical trial sites to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; organization certification services being testing, analysis, and evaluation of clinical research and clinical trial site competency, practices and processes to determine conformity with certification standards; certification services in relation to workforce quality namely the evaluation, checking, auditing and assurance of others to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; certification services in relation to clinical research and clinical trials being testing, analysis, and evaluation of clinical research and clinical trial site competency, practices and processes to determine conformity with certification standards; providing quality assurance services in relation to employee competency, namely the evaluation, checking, auditing and assurance of others to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; providing quality assurance services in relation to employer competency, namely the evaluation, checking, auditing and assurance of others to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; providing quality assurance services in relation to business competency, namely the evaluation, checking, auditing and assurance of clinical research sites and clinical trial sites to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; providing organization quality assurance services, namely the evaluation, checking, auditing and assurance of clinical research sites and clinical trial sites to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; quality assurance services in relation to workforce quality, namely the evaluation, checking, auditing and assurance of others to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; providing quality assurance services in relation to clinical research and clinical trials, namely the evaluation, checking, auditing and assurance of clinical research sites and clinical trial sites to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; quality checking in the nature of clinical research and clinical trial site competency, practices and processes to determine conformity with certification standards; quality testing in the nature of clinical research and clinical trial site competency, practices and processes to determine conformity with certification standards; quality auditing in the nature of clinical research and clinical trial site competency, practices and processes to determine conformity with certification standards; quality assessment in the nature of clinical research and clinical trial site competency, practices and processes to determine conformity with certification standards; testing services, namely, testing of clinical research and clinical trial sites; testing services for the certification of quality or standards, namely the evaluation, checking, auditing and assurance of clinical research sites to determine whether the organizations conform to an established accreditation standard of competency, practices and processes; information, advisory and consultancy services in relation to all of the aforementioned services | ACTIVE | — |
| 045 | Reviewing standards and practices to assure compliance with business, medical, clinical research and clinical trial laws and regulations; regulatory compliance auditing; review and preparation of regulations, standards and compliance procedures; review and preparation of regulations, standards and compliance procedures in relation to professional competency; review and preparation of regulations, standards and compliance procedures in relation to employee competency; review and preparation of regulations, standards and compliance procedures in relation to employer competency; review and preparation of regulations, standards and compliance procedures in relation to business competency; review and preparation of regulations, standards and compliance procedures for organizations; review and preparation of regulations, standards and compliance procedures in relation to workforce quality; review and preparation of regulations, standards and compliance procedures in relation to clinical research and clinical trials; information, advisory and consultancy services in relation to all of the aforementioned services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 27, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 11, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 10, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 24, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 24, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 24, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 23, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 6, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 6, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 22, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 22, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 2, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 13, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 12, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 12, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 12, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 16, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 8, 2024 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 14, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 26, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 7, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 1, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 1, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 1, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 13, 2023 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Aug 29, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 5, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 5, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 31, 2023 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Jun 29, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 28, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 11, 2023 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| May 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 17, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 16, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |